Back

The prognostic value of high-sensitivity cardiac troponin t in diabetes patients without coronary artery disease

25 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (1) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yi-Bo He

Guangdong Provincial Cardiovascular Institute, Guangzhou (China)

6 More presentations in this session

Presentation thumbnail
Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on markers of neurohumoral activation and left atrial strain.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Cardioprotective pharmacotherapy in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study
Professor S. Verma (Toronto, CA)
Abstract Slides
Presentation thumbnail
Incident cardiovascular disease in women with type 1 or type 2 diabetes by history of hypertensive disorders of pregnancy
Associate Professor S. Timpka (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Change in hbA1c following treatment with and the short-term risk of major adverse cardiovascular outcomes
Mrs B. Zareini (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial
thumbnail
Congress Presentation
Enhancing primary prevention: the incremental predictive value of high-sensitivity cardiac troponin T beyond ASCVD risk assessment
thumbnail
Congress Presentation
Practical considerations when implementing high-sensitivity troponins: how to advance cardiovascular risk stratification